If the page does not redirect, click here
New drug targets for a rare kidney and liver disease
Researchers have uncovered how mutations in a single gene called PKHD1 lead to symptoms associated with a rare kidney and liver disease, ARPKD (autosomal recessive polycystic kidney disease). The findings are expected to lead to novel treatment strategies against the disease.